Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Gentex (GNTX) Financials

Gentex logo
$22.56 -0.11 (-0.49%)
As of 10:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Gentex

Annual Income Statements for Gentex

This table shows Gentex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 318 348 407 438 425 348 361 319 428 404 385
Consolidated Net Income / (Loss)		 318 348 407 438 425 348 361 319 428 404 385
Net Income / (Loss) Continuing Operations		 318 348 407 438 425 348 361 319 428 404 385
Total Pre-Tax Income 		464 511 532 522 500 412 416 370 505 472 461
Total Operating Income		 459 512 523 508 489 400 410 370 496 460 474
Total Gross Profit		 604 668 695 690 688 605 620 610 763 771 867
Total Revenue		 1,544 1,679 1,795 1,834 1,859 1,688 1,731 1,919 2,299 2,313 2,534
Operating Revenue		 1,544 1,679 1,795 1,834 1,859 1,688 1,731 1,919 2,299 2,313 2,534
Total Cost of Revenue		 940 1,010 1,100 1,144 1,171 1,083 1,111 1,309 1,537 1,542 1,668
Operating Cost of Revenue		 940 1,010 1,100 1,144 1,171 1,083 1,111 1,309 1,537 1,542 1,668
Total Operating Expenses		 145 157 171 182 200 206 210 240 267 311 393
Selling, General & Admin Expense		 57 62 71 75 85 90 92 106 113 121 178
Research & Development Expense		 88 94 100 107 115 116 118 133 154 181 203
Other Operating Expenses / (Income)		 - - - - - - - - 0.00 0.00 12
Impairment Charge		 - - - - - - - 0.00 0.00 8.86 0.00
Total Other Income / (Expense), net		 4.83 -1.18 8.44 14 12 12 6.57 -0.28 9.25 12 -13
Interest & Investment Income		 4.99 4.79 9.44 11 11 6.99 3.59 4.80 13 13 -1.29
Other Income / (Expense), net		 -0.17 -5.97 -1.00 2.66 0.65 5.27 2.98 -5.08 -4.25 -0.92 -12
Income Tax Expense		 145 163 125 84 76 64 56 51 77 68 76
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - - - 0.00 0.00 -0.16
Basic Earnings per Share		 $1.09 $1.21 $1.42 $1.64 $1.67 $1.41 $1.51 $1.36 $1.84 $1.77 $1.74
Weighted Average Basic Shares Outstanding		 293.10M 288.43M 285.86M 267.79M 251.27M 243.67M 236.42M 234.18M 231.49M 227.20M 215.40M
Diluted Earnings per Share		 $1.08 $1.19 $1.41 $1.62 $1.66 $1.41 $1.50 $1.36 $1.84 $1.76 $1.74
Weighted Average Diluted Shares Outstanding		 293.10M 288.43M 285.86M 267.79M 251.27M 243.67M 236.42M 234.18M 231.49M 227.20M 215.40M
Weighted Average Basic & Diluted Shares Outstanding		 293.10M 288.43M 285.86M 267.79M 251.27M 243.67M 236.42M 234.18M 231.49M 227.20M 215.40M
Cash Dividends to Common per Share		 $0.34 $0.36 $0.39 $0.44 $0.46 $0.48 $0.48 $0.48 $0.48 $0.48 $0.48

Quarterly Income Statements for Gentex

This table shows Gentex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 105 117 108 86 123 88 95 96 101 93 98
Consolidated Net Income / (Loss)		 105 117 108 86 123 88 95 96 101 93 98
Net Income / (Loss) Continuing Operations		 105 117 108 86 123 88 95 96 101 93 98
Total Pre-Tax Income 		124 136 128 101 145 98 114 115 121 111 118
Total Operating Income		 122 133 129 115 126 90 113 119 122 120 124
Total Gross Profit		 191 203 202 189 204 176 192 225 225 225 229
Total Revenue		 576 589 590 573 609 542 577 658 655 644 675
Operating Revenue		 576 589 590 573 609 542 577 658 655 644 675
Total Cost of Revenue		 384 386 388 384 404 365 385 433 430 420 447
Operating Cost of Revenue		 384 386 388 384 404 365 385 433 430 420 447
Total Operating Expenses		 69 71 73 74 78 86 79 107 103 104 105
Selling, General & Admin Expense		 29 29 31 30 30 31 30 49 50 50 50
Research & Development Expense		 40 42 42 44 48 47 46 51 53 53 52
Other Operating Expenses / (Income)		 - - 0.00 0.00 0.00 - 2.89 6.78 0.52 1.45 0.72
Impairment Charge		 - - - - - - 0.00 - - - 2.80
Total Other Income / (Expense), net		 2.06 3.13 -1.70 -14 20 8.01 0.64 -3.05 -1.76 -8.71 -5.61
Interest & Investment Income		 3.85 3.82 -3.37 -12 19 10 4.87 -3.63 0.54 -3.08 -0.09
Other Income / (Expense), net		 -1.79 -0.69 1.67 -1.16 0.74 -2.17 -4.23 0.58 -2.30 -5.63 -5.52
Income Tax Expense		 20 19 19 15 23 10 19 20 20 18 20
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - 0.00 0.00 - 0.00 -0.39 -0.08 - -0.03
Basic Earnings per Share		 $0.45 $0.50 $0.47 $0.37 $0.54 $0.39 $0.42 $0.43 $0.46 $0.43 $0.46
Weighted Average Basic Shares Outstanding		 233.25M 231.49M 231.18M 230.22M 227.43M 227.20M 224.80M 219.49M 218.94M 215.40M 212.95M
Diluted Earnings per Share		 $0.45 $0.50 $0.47 $0.37 $0.53 $0.39 $0.42 $0.43 $0.46 $0.43 $0.46
Weighted Average Diluted Shares Outstanding		 233.25M 231.49M 231.18M 230.22M 227.43M 227.20M 224.80M 219.49M 218.94M 215.40M 212.95M
Weighted Average Basic & Diluted Shares Outstanding		 233.25M 231.49M 231.18M 230.22M 227.43M 227.20M 224.80M 219.49M 218.94M 215.40M 212.95M
Cash Dividends to Common per Share		 $0.12 $0.12 $0.12 $0.12 $0.12 $0.12 $0.12 $0.12 $0.12 $0.12 $0.12

Annual Cash Flow Statements for Gentex

This table details how cash moves in and out of Gentex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 54 -5.08 23 -353 79 127 -161 -44 7.68 6.88 -88
Net Cash From Operating Activities		 354 477 501 552 506 464 362 338 537 498 587
Net Cash From Continuing Operating Activities		 354 477 501 552 506 464 363 338 537 498 587
Net Income / (Loss) Continuing Operations		 318 348 407 438 425 348 361 319 428 404 385
Consolidated Net Income / (Loss)		 318 348 407 438 425 348 361 319 428 404 385
Depreciation Expense		 81 89 100 102 105 105 99 97 93 95 104
Non-Cash Adjustments To Reconcile Net Income		 15 20 18 16 22 29 27 32 45 52 60
Changes in Operating Assets and Liabilities, net		 -60 21 -23 -3.48 -45 -16 -124 -109 -30 -53 39
Net Cash From Investing Activities		 -90 -251 -78 -186 -57 26 -113 -173 -299 -202 -267
Net Cash From Continuing Investing Activities		 -90 -251 -78 -186 -57 26 -113 -173 -299 -202 -267
Purchase of Property, Plant & Equipment		 -98 -121 -104 -86 -85 -52 -69 -146 -184 -145 -129
Acquisitions		 - - - 0.00 0.00 -11 -25 0.00 -19 -2.87 -156
Purchase of Investments		 -48 -217 -30 -332 -153 -74 -100 -64 -152 -79 -65
Sale of Property, Plant & Equipment		 0.04 0.67 0.25 0.74 2.00 0.38 2.58 0.31 0.29 3.31 8.41
Sale and/or Maturity of Investments		 59 93 53 237 182 167 84 41 76 59 77
Other Investing Activities, net		 -2.84 -7.28 2.65 -5.60 -3.03 -4.33 -5.50 -4.00 -21 -38 -1.89
Net Cash From Financing Activities		 -211 -231 -400 -719 -370 -364 -410 -209 -230 -289 -408
Net Cash From Continuing Financing Activities		 -211 -231 -400 -719 -370 -364 -410 -209 -230 -289 -408
Repurchase of Common Equity		 -111 -163 -231 -592 -331 -288 -325 -113 -147 -206 -315
Payment of Dividends		 -97 -101 -109 -117 -116 -117 -115 -113 -112 -110 -107
Issuance of Common Equity		 30 81 48 67 78 42 30 17 29 27 14

Quarterly Cash Flow Statements for Gentex

This table details how cash moves in and out of Gentex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 23 -34 23 11 -81 54 53 -167 62 -36 19
Net Cash From Operating Activities		 126 170 130 129 85 154 149 166 147 125 137
Net Cash From Continuing Operating Activities		 126 170 130 129 85 154 149 166 147 125 137
Net Income / (Loss) Continuing Operations		 105 117 108 86 123 88 95 96 101 93 98
Consolidated Net Income / (Loss)		 105 117 108 86 123 88 95 96 101 93 98
Depreciation Expense		 22 22 24 24 23 24 26 27 26 25 26
Non-Cash Adjustments To Reconcile Net Income		 14 12 16 28 -4.71 12 11 15 18 15 21
Changes in Operating Assets and Liabilities, net		 -15 18 -18 -9.14 -56 31 17 28 2.11 -8.14 -7.72
Net Cash From Investing Activities		 -63 -110 -55 -47 -45 -55 -5.10 -176 -36 -50 -26
Net Cash From Continuing Investing Activities		 -63 -110 -55 -47 -45 -55 -5.10 -176 -36 -50 -26
Purchase of Property, Plant & Equipment		 -31 -62 -32 -32 -39 -42 -37 -31 -36 -26 -17
Acquisitions		 - - - - - - 0.00 - -13 -0.00 -5.49
Purchase of Investments		 -47 -39 -38 -23 -23 5.02 -12 -5.15 -13 -34 -4.48
Sale of Property, Plant & Equipment		 0.05 0.11 0.01 0.12 0.02 3.17 0.05 0.19 0.01 8.15 0.07
Sale and/or Maturity of Investments		 14 29 18 8.37 19 14 49 1.66 23 3.35 0.49
Other Investing Activities, net		 0.95 -19 -3.29 -0.84 -1.49 -32 -5.06 1.49 2.65 -0.96 0.88
Net Cash From Financing Activities		 -40 -93 -52 -71 -120 -46 -90 -157 -49 -112 -92
Net Cash From Continuing Financing Activities		 -40 -93 -52 -71 -120 -46 -90 -157 -49 -112 -92
Repurchase of Common Equity		 -23 -71 -41 -47 -97 -21 -68 -131 -30 -86 -69
Payment of Dividends		 -28 -28 -28 -28 -28 -27 -27 -27 -26 -26 -26
Issuance of Common Equity		 10 5.09 17 3.41 3.78 3.27 4.93 1.35 7.05 1.12 2.10

Annual Balance Sheets for Gentex

This table presents Gentex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,149 2,310 2,352 2,085 2,169 2,198 2,131 2,327 2,611 2,761 2,929
Total Current Assets		 984 1,155 1,185 851 950 979 873 949 998 1,037 1,128
Cash & Equivalents		 552 546 570 217 296 423 262 215 226 233 146
Short-Term Investments		 4.55 177 153 169 140 27 5.42 23 14 22 5.39
Accounts Receivable		 196 212 231 214 235 285 250 276 322 295 369
Inventories, net		 175 189 217 225 249 226 316 404 402 436 516
Prepaid Expenses		 57 31 14 26 29 18 39 26 33 50 93
Plant, Property, & Equipment, net		 413 466 492 498 498 468 464 550 653 728 791
Total Noncurrent Assets		 752 689 675 1,472 720 750 794 829 961 995 1,009
Long-Term Investments		 95 50 58 138 140 162 208 202 299 340 273
Goodwill		 307 307 307 307 307 312 314 314 340 341 357
Intangible Assets		 349 332 310 291 273 250 239 219 214 195 189
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - 4.80 26 41 53 108
Other Noncurrent Operating Assets		 - - - 736 - 27 29 68 67 66 81
Total Liabilities & Shareholders' Equity		 2,149 2,310 2,352 2,085 2,169 2,198 2,131 2,327 2,611 2,761 2,929
Total Liabilities		 426 399 303 224 231 234 193 261 299 289 438
Total Current Liabilities		 131 150 244 169 172 178 182 251 272 253 388
Short-Term Debt		 7.50 7.50 78 - - - - - - 0.00 3.80
Accounts Payable		 66 80 90 93 98 85 98 152 184 168 249
Accrued Expenses		 23 24 29 28 29 41 41 34 36 37 135
Total Noncurrent Liabilities		 295 249 59 55 59 56 12 11 27 36 50
Noncurrent Deferred & Payable Income Tax Liabilities		 70 71 59 55 51 39 - - - 0.00 0.91
Other Noncurrent Operating Liabilities		 - - - 0.00 7.41 17 12 11 27 36 49
Redeemable Noncontrolling Interest		 - - - - - - - - - 0.00 3.10
Total Equity & Noncontrolling Interests		 1,723 1,910 2,050 1,862 1,938 1,964 1,938 2,066 2,313 2,472 2,488
Total Preferred & Common Equity		 1,723 1,910 2,050 1,862 1,938 1,964 1,938 2,066 2,313 2,468 2,488
Total Common Equity		 1,723 1,910 2,050 1,862 1,938 1,964 1,938 2,066 2,313 2,468 2,488
Common Stock		 614 701 740 761 823 867 894 932 982 1,024 1,022
Retained Earnings		 1,109 1,211 1,302 1,102 1,116 1,090 1,042 1,148 1,337 1,450 1,466
Accumulated Other Comprehensive Income / (Loss)		 -1.13 -1.27 7.19 -1.60 -1.29 6.85 1.93 -14 -6.56 -6.41 0.27
Noncontrolling Interest		 - - - - - - - - 0.00 4.15 0.00

Quarterly Balance Sheets for Gentex

This table presents Gentex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 2,311 2,433 2,487 2,558 2,713 2,738 2,735 2,783 2,814 2,939 2,998
Total Current Assets		 989 1,005 1,025 1,055 1,073 1,084 1,046 1,089 1,062 1,168 1,208
Cash & Equivalents		 223 215 238 261 249 260 180 287 120 179 165
Short-Term Investments		 16 26 20 17 17 16 20 21 21 4.82 10
Accounts Receivable		 292 333 350 351 342 307 356 331 373 385 419
Inventories, net		 418 402 390 395 437 463 449 409 476 499 524
Prepaid Expenses		 40 25 27 31 29 38 40 42 72 101 90
Plant, Property, & Equipment, net		 527 575 597 606 665 679 704 735 784 799 786
Total Noncurrent Assets		 795 853 865 897 976 975 986 959 968 971 1,003
Long-Term Investments		 194 229 240 273 311 308 326 301 267 247 270
Goodwill		 314 314 314 313 340 340 340 341 341 357 361
Intangible Assets		 224 215 210 205 210 206 202 191 187 191 186
Noncurrent Deferred & Refundable Income Taxes		 - 24 29 37 45 52 50 54 91 93 109
Other Noncurrent Operating Assets		 63 72 73 70 70 69 69 74 83 82 77
Total Liabilities & Shareholders' Equity		 2,311 2,433 2,487 2,558 2,713 2,738 2,735 2,783 2,814 2,939 2,998
Total Liabilities		 277 310 291 290 337 338 318 303 381 441 492
Total Current Liabilities		 265 297 276 274 304 305 283 267 337 394 445
Short-Term Debt		 - - - - - - - - 3.93 4.13 3.84
Accounts Payable		 171 167 168 171 192 206 183 163 205 252 277
Accrued Expenses		 94 130 108 103 113 99 101 104 128 138 164
Total Noncurrent Liabilities		 12 13 15 15 32 33 35 36 44 47 47
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - - 1.67 0.94
Other Noncurrent Operating Liabilities		 12 13 15 15 32 33 35 36 44 45 47
Redeemable Noncontrolling Interest		 - - - - - - - - 2.49 2.32 3.02
Total Equity & Noncontrolling Interests		 2,034 2,123 2,196 2,268 2,376 2,400 2,418 2,479 2,431 2,495 2,503
Total Preferred & Common Equity		 2,034 2,123 2,196 2,268 2,376 2,400 2,418 2,475 2,430 2,495 2,503
Total Common Equity		 2,034 2,123 2,196 2,268 2,376 2,400 2,418 2,475 2,430 2,495 2,503
Common Stock		 923 942 957 975 1,005 1,014 1,015 1,025 1,012 1,026 1,020
Retained Earnings		 1,108 1,193 1,253 1,307 1,379 1,394 1,406 1,455 1,421 1,472 1,481
Accumulated Other Comprehensive Income / (Loss)		 3.29 -12 -13 -14 -7.47 -7.98 -2.89 -5.03 -3.40 -2.65 1.22
Noncontrolling Interest		 - - - - - - - 4.59 0.60 0.00 0.00

Annual Metrics And Ratios for Gentex

This table displays calculated financial ratios and metrics derived from Gentex's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 12.22% 8.77% 6.91% 2.18% 1.35% -9.18% 2.55% 10.85% 19.82% 0.61% 9.55%
EBITDA Growth		 10.79% 10.23% 4.64% -1.44% -3.11% -14.20% 0.45% -9.84% 26.72% -5.35% 2.32%
EBIT Growth		 12.04% 10.29% 3.28% -2.21% -4.23% -17.24% 1.96% -11.59% 34.68% -6.65% 0.77%
NOPAT Growth		 13.72% 10.55% 14.91% 6.46% -2.72% -18.66% 5.30% -10.17% 31.84% -6.36% 0.41%
Net Income Growth		 10.35% 9.14% 17.03% 7.64% -3.01% -18.16% 3.81% -11.65% 34.40% -5.58% -4.90%
EPS Growth		 10.20% 10.19% 18.49% 14.89% 2.47% -15.06% 6.38% -9.33% 35.29% -4.35% -1.14%
Operating Cash Flow Growth		 8.31% 34.60% 5.02% 10.26% -8.41% -8.20% -22.03% -6.62% 58.86% -7.27% 17.85%
Free Cash Flow Firm Growth		 0.66% 40.23% 13.50% -180.40% 475.10% -69.19% -29.45% -34.58% 68.57% 7.46% -30.02%
Invested Capital Growth		 6.45% 1.46% 2.00% 52.81% -33.85% -0.70% 7.99% 10.66% 9.13% 5.76% 10.11%
Revenue Q/Q Growth		 3.71% 0.86% 2.26% -0.33% -0.51% 5.37% -5.98% 4.00% 4.33% -2.01% 4.23%
EBITDA Q/Q Growth		 5.00% 0.69% 2.02% -1.57% -2.06% 11.85% -13.47% 1.39% 6.80% -7.21% 5.26%
EBIT Q/Q Growth		 6.11% 0.24% 1.42% -1.25% -3.25% 15.09% -15.79% 1.97% 8.43% -8.84% 6.17%
NOPAT Q/Q Growth		 6.68% 0.28% 10.80% -5.48% -1.14% 14.81% -14.00% 0.65% 7.49% -7.84% 5.22%
Net Income Q/Q Growth		 5.79% 0.11% 11.42% -5.24% -1.56% 14.42% -14.09% 0.63% 7.74% -6.75% 1.48%
EPS Q/Q Growth		 4.85% -1.65% 9.30% -3.57% 0.00% 14.63% -12.79% 0.74% 7.60% -5.88% 2.35%
Operating Cash Flow Q/Q Growth		 -7.45% 11.55% 5.88% 1.05% -5.98% 2.98% -16.71% 13.06% 14.43% -2.96% -4.69%
Free Cash Flow Firm Q/Q Growth		 -14.90% 17.49% -14.04% -193.52% 160.54% 3.19% -22.38% 31.12% -1.62% 14.62% 3.10%
Invested Capital Q/Q Growth		 7.22% 3.18% 11.47% 54.12% 2.91% 5.51% 6.04% 3.06% 4.81% 0.64% 1.24%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 39.11% 39.81% 38.70% 37.65% 37.03% 35.86% 35.80% 31.78% 33.17% 33.33% 34.20%
EBITDA Margin		 34.93% 35.40% 34.65% 33.42% 31.95% 30.18% 29.57% 24.05% 25.43% 23.93% 22.35%
Operating Margin		 29.72% 30.48% 29.16% 27.70% 26.28% 23.67% 23.67% 19.28% 21.56% 19.87% 18.70%
EBIT Margin		 29.71% 30.12% 29.10% 27.85% 26.32% 23.98% 23.84% 19.02% 21.38% 19.83% 18.24%
Profit (Net Income) Margin		 20.63% 20.70% 22.66% 23.88% 22.85% 20.59% 20.84% 16.61% 18.63% 17.49% 15.18%
Tax Burden Percent		 68.70% 68.08% 76.49% 83.88% 84.87% 84.40% 86.66% 86.22% 84.84% 85.66% 83.43%
Interest Burden Percent		 101.09% 100.95% 101.81% 102.20% 102.30% 101.73% 100.87% 101.31% 102.75% 102.92% 99.72%
Effective Tax Rate		 31.30% 31.92% 23.51% 16.12% 15.13% 15.60% 13.34% 13.78% 15.16% 14.34% 16.57%
Return on Invested Capital (ROIC)		 24.45% 26.02% 29.39% 24.51% 23.74% 24.34% 24.73% 20.31% 24.38% 21.26% 19.77%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.53% 26.19% 28.35% 19.13% 17.19% 22.51% 23.63% 20.37% 22.69% 19.28% 22.00%
Return on Net Nonoperating Assets (RNNOA)		 -5.12% -6.89% -8.85% -2.12% -1.39% -6.52% -6.24% -4.39% -4.81% -4.35% -4.27%
Return on Equity (ROE)		 19.34% 19.14% 20.55% 22.39% 22.35% 17.81% 18.49% 15.92% 19.57% 16.91% 15.50%
Cash Return on Invested Capital (CROIC)		 18.20% 24.57% 27.42% -17.27% 64.49% 25.04% 17.05% 10.20% 15.65% 15.66% 10.15%
Operating Return on Assets (OROA)		 21.99% 22.69% 22.41% 23.02% 23.00% 18.54% 19.07% 16.37% 19.90% 17.08% 16.25%
Return on Assets (ROA)		 15.27% 15.59% 17.45% 19.74% 19.97% 15.92% 16.67% 14.30% 17.35% 15.06% 13.52%
Return on Common Equity (ROCE)		 19.34% 19.14% 20.55% 22.39% 22.35% 17.81% 18.49% 15.92% 19.57% 16.89% 15.48%
Return on Equity Simple (ROE_SIMPLE)		 18.49% 18.19% 19.85% 23.52% 21.91% 17.70% 18.62% 15.43% 18.53% 16.39% 0.00%
Net Operating Profit after Tax (NOPAT)		 315 348 400 426 415 337 355 319 421 394 395
NOPAT Margin		 20.42% 20.75% 22.30% 23.24% 22.30% 19.98% 20.51% 16.62% 18.29% 17.02% 15.60%
Net Nonoperating Expense Percent (NNEP)		 0.93% -0.17% 1.04% 5.38% 6.56% 1.83% 1.11% -0.06% 1.69% 1.98% -2.23%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 15.44% 18.19% 15.93% 15.87%
Cost of Revenue to Revenue		 60.89% 60.19% 61.30% 62.35% 62.97% 64.14% 64.20% 68.22% 66.83% 66.67% 65.80%
SG&A Expenses to Revenue		 3.67% 3.72% 3.98% 4.10% 4.58% 5.33% 5.32% 5.55% 4.89% 5.23% 7.02%
R&D to Revenue		 5.73% 5.61% 5.56% 5.84% 6.17% 6.87% 6.80% 6.95% 6.71% 7.84% 8.02%
Operating Expenses to Revenue		 9.39% 9.33% 9.54% 9.94% 10.75% 12.20% 12.13% 12.50% 11.61% 13.46% 15.50%
Earnings before Interest and Taxes (EBIT)		 459 506 522 511 489 405 413 365 491 459 462
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 539 594 622 613 594 510 512 461 585 554 566
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.32 2.58 2.59 2.58 3.51 4.00 4.07 2.99 3.23 2.64 2.04
Price to Tangible Book Value (P/TBV)		 3.74 3.88 3.70 3.81 5.00 5.60 5.70 4.03 4.25 3.37 2.61
Price to Revenue (P/Rev)		 2.59 2.94 2.95 2.62 3.65 4.65 4.56 3.22 3.25 2.81 2.00
Price to Earnings (P/E)		 12.53 14.19 13.03 10.99 16.00 22.58 21.86 19.36 17.44 16.08 13.17
Dividend Yield		 2.41% 2.03% 2.04% 2.34% 1.69% 1.48% 1.44% 1.82% 1.50% 1.68% 2.07%
Earnings Yield		 7.98% 7.05% 7.68% 9.10% 6.25% 4.43% 4.57% 5.16% 5.73% 6.22% 7.59%
Enterprise Value to Invested Capital (EV/IC)		 2.69 3.22 3.34 2.04 4.47 5.24 4.97 3.47 3.85 3.11 2.22
Enterprise Value to Revenue (EV/Rev)		 2.31 2.59 2.56 2.34 3.34 4.29 4.28 2.99 3.02 2.56 1.84
Enterprise Value to EBITDA (EV/EBITDA)		 6.63 7.31 7.39 6.99 10.47 14.20 14.48 12.41 11.85 10.69 8.21
Enterprise Value to EBIT (EV/EBIT)		 7.79 8.59 8.80 8.39 12.71 17.87 17.96 15.70 14.11 12.89 10.06
Enterprise Value to NOPAT (EV/NOPAT)		 11.34 12.47 11.48 10.06 15.00 21.45 20.87 17.96 16.48 15.02 11.77
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.08 9.10 9.17 7.76 12.29 15.57 20.47 16.94 12.90 11.87 7.92
Enterprise Value to Free Cash Flow (EV/FCFF)		 15.23 13.20 12.31 0.00 5.52 20.85 30.28 35.77 25.68 20.39 22.92
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.14 0.10 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.13 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.22 -0.26 -0.31 -0.11 -0.08 -0.29 -0.26 -0.22 -0.21 -0.23 -0.19
Leverage Ratio		 1.27 1.23 1.18 1.13 1.12 1.12 1.11 1.11 1.13 1.12 1.15
Compound Leverage Factor		 1.28 1.24 1.20 1.16 1.15 1.14 1.12 1.13 1.16 1.16 1.14
Debt to Total Capital		 11.92% 8.86% 3.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.15%
Short-Term Debt to Total Capital		 0.38% 0.36% 3.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.15%
Long-Term Debt to Total Capital		 11.54% 8.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.17% 0.12%
Common Equity to Total Capital		 88.08% 91.14% 96.33% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.83% 99.72%
Debt to EBITDA		 0.43 0.31 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Net Debt to EBITDA		 -0.78 -0.99 -1.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.74
Long-Term Debt to EBITDA		 0.42 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.74 0.53 0.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Net Debt to NOPAT		 -1.33 -1.69 -1.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.06
Long-Term Debt to NOPAT		 0.72 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 8.24 10.12 13.26 15.73 20.42 22.63 27.00 16.56 17.55 15.98 9.34
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.15%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.51 7.71 4.86 5.03 5.53 5.51 4.81 3.79 3.67 4.11 2.91
Quick Ratio		 5.74 6.24 3.91 3.55 3.91 4.14 2.85 2.05 2.07 2.18 1.34
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 235 329 373 -300 1,126 347 245 160 270 290 203
Operating Cash Flow to CapEx		 362.03% 396.58% 482.70% 647.98% 612.71% 905.03% 546.61% 231.46% 292.96% 352.45% 486.51%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.74 0.75 0.77 0.83 0.87 0.77 0.80 0.86 0.93 0.86 0.89
Accounts Receivable Turnover		 8.48 8.24 8.11 8.25 8.28 6.49 6.48 7.29 7.69 7.50 7.63
Inventory Turnover		 5.94 5.55 5.42 5.17 4.94 4.56 4.10 3.63 3.81 3.68 3.50
Fixed Asset Turnover		 3.93 3.82 3.75 3.70 3.73 3.49 3.71 3.78 3.82 3.35 3.34
Accounts Payable Turnover		 13.64 13.81 12.96 12.52 12.30 11.88 12.14 10.47 9.14 8.74 7.99
Days Sales Outstanding (DSO)		 43.03 44.30 45.01 44.25 44.08 56.25 56.37 50.05 47.49 48.69 47.81
Days Inventory Outstanding (DIO)		 61.45 65.74 67.35 70.54 73.93 80.10 89.09 100.46 95.83 99.28 104.27
Days Payable Outstanding (DPO)		 26.76 26.43 28.17 29.16 29.68 30.73 30.07 34.86 39.92 41.74 45.67
Cash Conversion Cycle (CCC)		 77.72 83.62 84.19 85.63 88.33 105.62 115.39 115.65 103.39 106.23 106.41
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,329 1,349 1,375 2,102 1,390 1,381 1,491 1,650 1,800 1,904 2,097
Invested Capital Turnover		 1.20 1.25 1.32 1.05 1.06 1.22 1.21 1.22 1.33 1.25 1.27
Increase / (Decrease) in Invested Capital		 81 19 27 726 -712 -9.75 110 159 151 104 192
Enterprise Value (EV)		 3,573 4,343 4,597 4,287 6,217 7,234 7,412 5,728 6,933 5,915 4,653
Market Capitalization		 3,991 4,931 5,299 4,812 6,794 7,846 7,888 6,172 7,473 6,506 5,070
Book Value per Share		 $5.91 $6.67 $7.22 $7.10 $7.66 $8.01 $8.19 $8.81 $9.91 $10.85 $11.36
Tangible Book Value per Share		 $3.66 $4.44 $5.05 $4.82 $5.37 $5.72 $5.86 $6.53 $7.54 $8.50 $8.87
Total Capital		 1,956 2,096 2,128 1,862 1,938 1,964 1,938 2,066 2,313 2,472 2,495
Total Debt		 233 186 78 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80
Total Long-Term Debt		 226 178 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -418 -588 -702 -524 -577 -613 -475 -444 -540 -595 -420
Capital Expenditures (CapEx)		 98 120 104 85 83 51 66 146 183 141 121
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 304 289 297 295 342 351 424 456 485 529 594
Debt-free Net Working Capital (DFNWC)		 861 1,013 1,019 682 779 802 691 698 726 785 745
Net Working Capital (NWC)		 853 1,005 941 682 779 802 691 698 726 785 741
Net Nonoperating Expense (NNE)		 -3.31 0.80 -6.45 -12 -10 -10 -5.69 0.24 -7.85 -11 11
Net Nonoperating Obligations (NNO)		 -393 -562 -674 240 -548 -583 -447 -416 -512 -568 -394
Total Depreciation and Amortization (D&A)		 81 89 100 102 105 105 99 97 93 95 104
Debt-free, Cash-free Net Working Capital to Revenue		 19.72% 17.22% 16.53% 16.10% 18.39% 20.80% 24.47% 23.78% 21.11% 22.87% 23.43%
Debt-free Net Working Capital to Revenue		 55.75% 60.31% 56.77% 37.17% 41.88% 47.48% 39.93% 36.38% 31.58% 33.92% 29.38%
Net Working Capital to Revenue		 55.26% 59.87% 52.42% 37.17% 41.88% 47.48% 39.93% 36.38% 31.58% 33.92% 29.23%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.09 $1.21 $1.42 $1.64 $1.67 $1.41 $1.51 $1.36 $1.84 $1.77 $1.74
Adjusted Weighted Average Basic Shares Outstanding		 288.89M 287.30M 274.42M 259.23M 251.27M 243.67M 236.42M 234.18M 231.49M 227.20M 215.40M
Adjusted Diluted Earnings per Share		 $1.08 $1.19 $1.41 $1.62 $1.66 $1.41 $1.50 $1.36 $1.84 $1.76 $1.74
Adjusted Weighted Average Diluted Shares Outstanding		 288.89M 287.30M 274.42M 259.23M 251.27M 243.67M 236.42M 234.18M 231.49M 227.20M 215.40M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 288.89M 287.30M 274.42M 259.23M 251.27M 243.67M 236.42M 234.18M 231.49M 227.20M 215.40M
Normalized Net Operating Profit after Tax (NOPAT)		 315 348 400 426 415 337 355 319 421 401 395
Normalized NOPAT Margin		 20.42% 20.75% 22.30% 23.24% 22.30% 19.98% 20.51% 16.62% 18.29% 17.35% 15.60%
Pre Tax Income Margin		 30.03% 30.41% 29.63% 28.46% 26.92% 24.39% 24.05% 19.27% 21.96% 20.41% 18.19%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 30.46% 29.09% 26.75% 26.62% 27.39% 33.72% 31.95% 35.48% 26.18% 27.30% 27.78%
Augmented Payout Ratio		 65.38% 76.09% 83.62% 161.72% 105.44% 116.72% 121.93% 70.78% 60.59% 78.26% 109.79%

Quarterly Metrics And Ratios for Gentex

This table displays calculated financial ratios and metrics derived from Gentex's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 215,402,363.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 215,402,363.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.46
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 16.65% 19.34% 7.17% -1.81% 5.67% -8.06% -2.28% 14.82% 7.68% 18.97% 17.11%
EBITDA Growth		 32.33% 31.79% 13.04% -8.50% 4.64% -27.84% -13.36% 6.36% -2.32% 25.38% 7.10%
EBIT Growth		 42.48% 40.70% 15.89% -9.54% 4.85% -33.68% -16.99% 4.73% -5.10% 30.68% 8.63%
NOPAT Growth		 40.72% 34.48% 15.12% -9.71% 2.85% -29.56% -13.98% 0.64% -3.37% 24.95% 9.29%
Net Income Growth		 44.14% 35.72% 10.92% -21.18% 17.02% -25.03% -12.34% 11.17% -17.68% 6.39% 3.74%
EPS Growth		 45.16% 35.14% 11.90% -21.28% 17.78% -22.00% -10.64% 16.22% -13.21% 10.26% 9.52%
Operating Cash Flow Growth		 167.33% 66.51% 7.41% 6.95% -32.73% -8.95% 14.34% 28.54% 73.55% -18.72% -7.69%
Free Cash Flow Firm Growth		 88.60% 50.79% 52.70% 75.35% -392.36% 36.12% 154.04% -459.33% -12.14% -295.45% -502.75%
Invested Capital Growth		 7.30% 9.13% 9.15% 6.95% 10.14% 5.76% 4.01% 11.70% 9.46% 10.11% 10.29%
Revenue Q/Q Growth		 -1.31% 2.31% 0.19% -2.93% 6.21% -10.99% 6.49% 14.06% -0.40% -1.65% 4.82%
EBITDA Q/Q Growth		 -5.13% 8.14% 0.37% -11.14% 8.50% -25.43% 20.50% 9.09% -0.35% -4.28% 2.93%
EBIT Q/Q Growth		 -4.04% 9.50% -0.81% -13.20% 11.21% -30.74% 24.15% 9.51% 0.78% -4.63% 3.20%
NOPAT Q/Q Growth		 -4.67% 10.94% -4.01% -11.05% 8.59% -24.02% 17.21% 4.07% 4.26% -1.75% 2.52%
Net Income Q/Q Growth		 -4.06% 11.67% -7.45% -20.50% 42.43% -28.46% 8.22% 0.82% 5.47% -7.55% 5.52%
EPS Q/Q Growth		 -4.26% 11.11% -6.00% -21.28% 43.24% -26.42% 7.69% 2.38% 6.98% -6.52% 6.98%
Operating Cash Flow Q/Q Growth		 4.18% 34.69% -23.41% -0.48% -34.48% 82.31% -3.81% 11.87% -11.53% -14.62% 9.23%
Free Cash Flow Firm Q/Q Growth		 83.26% -162.18% -378.68% 50.32% -234.24% 65.98% 195.67% -614.16% 32.99% -19.97% 2.56%
Invested Capital Q/Q Growth		 1.13% 4.81% 1.52% 0.94% 4.16% 0.64% -1.70% 8.40% 2.07% 1.24% -1.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 33.25% 34.52% 34.26% 32.91% 33.53% 32.54% 33.24% 34.25% 34.36% 34.84% 33.85%
EBITDA Margin		 24.80% 26.21% 26.26% 24.04% 24.55% 20.57% 23.28% 22.26% 22.28% 21.68% 21.29%
Operating Margin		 21.26% 22.54% 21.91% 20.05% 20.66% 16.57% 19.59% 18.02% 18.67% 18.64% 18.31%
EBIT Margin		 20.95% 22.42% 22.20% 19.85% 20.78% 16.17% 18.86% 18.10% 18.32% 17.76% 17.49%
Profit (Net Income) Margin		 18.19% 19.85% 18.34% 15.02% 20.14% 16.19% 16.45% 14.54% 15.40% 14.47% 14.57%
Tax Burden Percent		 84.13% 86.05% 84.79% 84.91% 84.25% 89.66% 83.50% 82.84% 83.67% 83.73% 83.37%
Interest Burden Percent		 103.19% 102.89% 97.43% 89.10% 115.01% 111.62% 104.48% 96.95% 100.45% 97.31% 99.93%
Effective Tax Rate		 15.87% 13.95% 15.21% 15.09% 15.75% 10.34% 16.50% 17.16% 16.33% 16.27% 16.63%
Return on Invested Capital (ROIC)		 23.75% 25.85% 25.20% 22.55% 22.77% 18.56% 20.49% 18.51% 19.17% 19.77% 20.42%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.40% 25.27% 25.48% 24.68% 19.68% 17.23% 20.40% 19.02% 19.48% 21.29% 21.31%
Return on Net Nonoperating Assets (RNNOA)		 -5.35% -5.36% -5.95% -5.81% -4.52% -3.89% -4.98% -3.89% -3.77% -4.13% -4.49%
Return on Equity (ROE)		 18.40% 20.49% 19.25% 16.75% 18.25% 14.67% 15.52% 14.62% 15.40% 15.64% 15.94%
Cash Return on Invested Capital (CROIC)		 16.54% 15.65% 16.48% 17.44% 14.02% 15.66% 16.69% 8.67% 9.94% 10.15% 10.75%
Operating Return on Assets (OROA)		 18.96% 20.88% 20.17% 17.69% 18.54% 13.93% 15.78% 15.55% 15.70% 15.83% 15.93%
Return on Assets (ROA)		 16.46% 18.48% 16.67% 13.38% 17.96% 13.94% 13.77% 12.49% 13.20% 12.89% 13.27%
Return on Common Equity (ROCE)		 18.40% 20.49% 19.25% 16.75% 18.25% 14.66% 15.50% 14.61% 15.39% 15.62% 15.91%
Return on Equity Simple (ROE_SIMPLE)		 17.53% 0.00% 18.48% 17.33% 17.94% 0.00% 15.80% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 103 114 110 98 106 80 94 98 102 101 103
NOPAT Margin		 17.88% 19.39% 18.58% 17.03% 17.41% 14.86% 16.36% 14.92% 15.62% 15.61% 15.26%
Net Nonoperating Expense Percent (NNEP)		 0.35% 0.58% -0.27% -2.13% 3.09% 1.33% 0.09% -0.51% -0.31% -1.52% -0.89%
Return On Investment Capital (ROIC_SIMPLE)		 - 4.94% - - - 3.26% 3.80% 4.03% 4.10% 4.04% 4.11%
Cost of Revenue to Revenue		 66.76% 65.48% 65.74% 67.09% 66.47% 67.46% 66.76% 65.75% 65.64% 65.16% 66.15%
SG&A Expenses to Revenue		 5.01% 4.93% 5.20% 5.18% 4.95% 5.64% 5.19% 7.37% 7.58% 7.72% 7.37%
R&D to Revenue		 6.98% 7.05% 7.15% 7.68% 7.93% 8.69% 7.96% 7.82% 8.03% 8.26% 7.65%
Operating Expenses to Revenue		 11.99% 11.98% 12.35% 12.86% 12.87% 15.96% 13.65% 16.23% 15.70% 16.20% 15.54%
Earnings before Interest and Taxes (EBIT)		 121 132 131 114 126 88 109 119 120 114 118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 143 154 155 138 149 111 134 146 146 140 144
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.29 3.23 3.52 3.24 2.82 2.64 2.13 2.02 2.48 2.04 1.87
Price to Tangible Book Value (P/TBV)		 4.26 4.25 4.58 4.19 3.63 3.37 2.71 2.58 3.18 2.61 2.39
Price to Revenue (P/Rev)		 3.38 3.25 3.58 3.34 2.88 2.81 2.29 2.06 2.54 2.00 1.78
Price to Earnings (P/E)		 18.75 17.44 19.06 18.67 15.69 16.08 13.46 12.26 16.29 13.17 12.05
Dividend Yield		 1.50% 1.50% 1.34% 1.43% 1.62% 1.68% 2.07% 2.19% 1.70% 2.07% 2.21%
Earnings Yield		 5.33% 5.73% 5.25% 5.36% 6.37% 6.22% 7.43% 8.16% 6.14% 7.59% 8.30%
Enterprise Value to Invested Capital (EV/IC)		 4.02 3.85 4.33 3.95 3.32 3.11 2.49 2.23 2.78 2.22 2.05
Enterprise Value to Revenue (EV/Rev)		 3.13 3.02 3.33 3.08 2.66 2.56 2.03 1.89 2.37 1.84 1.61
Enterprise Value to EBITDA (EV/EBITDA)		 12.61 11.85 12.93 12.17 10.53 10.69 8.75 8.34 10.70 8.21 7.37
Enterprise Value to EBIT (EV/EBIT)		 15.23 14.11 15.29 14.44 12.48 12.89 10.67 10.22 13.23 10.06 8.99
Enterprise Value to NOPAT (EV/NOPAT)		 17.65 16.48 17.91 16.92 14.70 15.02 12.31 11.91 15.32 11.77 10.49
Enterprise Value to Operating Cash Flow (EV/OCF)		 14.71 12.90 14.26 12.95 12.23 11.87 9.02 8.16 9.35 7.92 7.37
Enterprise Value to Free Cash Flow (EV/FCFF)		 25.16 25.68 27.41 23.43 24.82 20.39 15.21 27.08 29.25 22.92 20.05
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.23 -0.21 -0.23 -0.24 -0.23 -0.23 -0.24 -0.20 -0.19 -0.19 -0.21
Leverage Ratio		 1.13 1.13 1.14 1.14 1.13 1.12 1.13 1.15 1.15 1.15 1.16
Compound Leverage Factor		 1.17 1.16 1.11 1.01 1.30 1.25 1.18 1.11 1.16 1.12 1.16
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.17% 0.15% 0.15%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.17% 0.15% 0.15%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.17% 0.19% 0.13% 0.09% 0.12% 0.12%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 99.83% 99.81% 99.71% 99.74% 99.72% 99.73%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.75 -0.79 -0.74 -0.77
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.07 -1.14 -1.06 -1.09
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 17.53 17.10 16.98 15.83 14.93 15.54 12.46 9.75 10.39 8.95 7.71
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.09% 0.06% 0.05% 0.15% 0.15%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.85 3.67 3.52 3.56 3.69 4.11 4.08 3.15 2.96 2.91 2.72
Quick Ratio		 2.29 2.07 2.00 1.91 1.97 2.18 2.39 1.53 1.44 1.34 1.34
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -14 -36 -41 -20 -68 -23 22 -114 -77 -92 -90
Operating Cash Flow to CapEx		 405.21% 272.74% 407.63% 408.43% 215.41% 400.67% 404.99% 537.32% 413.21% 716.27% 807.71%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.91 0.93 0.91 0.89 0.89 0.86 0.84 0.86 0.86 0.89 0.91
Accounts Receivable Turnover		 6.85 7.69 6.94 7.09 6.67 7.50 6.84 7.02 6.56 7.63 7.02
Inventory Turnover		 3.66 3.81 3.69 3.61 3.70 3.68 3.64 3.38 3.40 3.50 3.71
Fixed Asset Turnover		 3.89 3.82 3.77 3.65 3.60 3.35 3.29 3.26 3.24 3.34 3.46
Accounts Payable Turnover		 8.70 9.14 8.64 8.24 8.83 8.74 8.68 7.73 7.42 7.99 7.87
Days Sales Outstanding (DSO)		 53.30 47.49 52.63 51.50 54.69 48.69 53.34 52.00 55.62 47.81 51.99
Days Inventory Outstanding (DIO)		 99.63 95.83 98.80 100.98 98.66 99.28 100.24 107.97 107.32 104.27 98.40
Days Payable Outstanding (DPO)		 41.97 39.92 42.27 44.30 41.34 41.74 42.05 47.21 49.17 45.67 46.39
Cash Conversion Cycle (CCC)		 110.95 103.39 109.16 108.18 112.01 106.23 111.54 112.76 113.76 106.41 104.01
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,718 1,800 1,800 1,816 1,892 1,904 1,872 2,029 2,071 2,097 2,064
Invested Capital Turnover		 1.33 1.33 1.36 1.32 1.31 1.25 1.25 1.24 1.23 1.27 1.34
Increase / (Decrease) in Invested Capital		 117 151 151 118 174 104 72 212 179 192 193
Enterprise Value (EV)		 6,905 6,933 7,790 7,182 6,281 5,915 4,660 4,517 5,759 4,653 4,242
Market Capitalization		 7,455 7,473 8,367 7,766 6,807 6,506 5,263 4,918 6,184 5,070 4,680
Book Value per Share		 $9.72 $9.91 $10.28 $10.38 $10.50 $10.85 $10.89 $10.81 $11.37 $11.36 $11.62
Tangible Book Value per Share		 $7.50 $7.54 $7.90 $8.02 $8.15 $8.50 $8.55 $8.46 $8.87 $8.87 $9.08
Total Capital		 2,268 2,313 2,376 2,400 2,418 2,472 2,479 2,437 2,502 2,495 2,509
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.93 4.13 3.80 3.84
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -551 -540 -577 -584 -526 -595 -608 -404 -427 -420 -441
Capital Expenditures (CapEx)		 31 62 32 32 39 39 37 31 36 18 17
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 503 485 502 503 562 529 515 588 595 594 592
Debt-free Net Working Capital (DFNWC)		 781 726 768 779 763 785 822 729 778 745 767
Net Working Capital (NWC)		 781 726 768 779 763 785 822 725 774 741 764
Net Nonoperating Expense (NNE)		 -1.74 -2.69 1.44 12 -17 -7.18 -0.53 2.53 1.47 7.29 4.68
Net Nonoperating Obligations (NNO)		 -551 -512 -577 -584 -526 -568 -608 -404 -427 -394 -441
Total Depreciation and Amortization (D&A)		 22 22 24 24 23 24 26 27 26 25 26
Debt-free, Cash-free Net Working Capital to Revenue		 22.82% 21.11% 21.48% 21.62% 23.82% 22.87% 22.39% 24.65% 24.46% 23.43% 22.50%
Debt-free Net Working Capital to Revenue		 35.44% 31.58% 32.85% 33.47% 32.30% 33.92% 35.74% 30.57% 32.00% 29.38% 29.15%
Net Working Capital to Revenue		 35.44% 31.58% 32.85% 33.47% 32.30% 33.92% 35.74% 30.40% 31.83% 29.23% 29.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.45 $0.50 $0.47 $0.37 $0.54 $0.39 $0.42 $0.43 $0.46 $0.43 $0.46
Adjusted Weighted Average Basic Shares Outstanding		 233.25M 231.49M 231.18M 230.22M 227.43M 227.20M 224.80M 219.49M 218.94M 215.40M 212.95M
Adjusted Diluted Earnings per Share		 $0.45 $0.50 $0.47 $0.37 $0.53 $0.39 $0.42 $0.43 $0.46 $0.43 $0.46
Adjusted Weighted Average Diluted Shares Outstanding		 233.25M 231.49M 231.18M 230.22M 227.43M 227.20M 224.80M 219.49M 218.94M 215.40M 212.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 233.25M 231.49M 231.18M 230.22M 227.43M 227.20M 224.80M 219.49M 218.94M 215.40M 212.95M
Normalized Net Operating Profit after Tax (NOPAT)		 103 114 110 98 106 80 94 98 102 101 105
Normalized NOPAT Margin		 17.88% 19.39% 18.58% 17.03% 17.41% 14.86% 16.36% 14.92% 15.62% 15.61% 15.61%
Pre Tax Income Margin		 21.62% 23.07% 21.63% 17.69% 23.90% 18.05% 19.70% 17.55% 18.40% 17.29% 17.48%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 28.25% 26.18% 25.47% 26.81% 25.62% 27.30% 28.11% 27.24% 28.46% 27.78% 27.16%
Augmented Payout Ratio		 54.79% 60.59% 62.58% 70.37% 84.44% 78.26% 87.60% 106.35% 94.55% 109.79% 108.64%

Financials Breakdown Chart

Key Financial Trends

Gentex (GNTX) has shown a generally constructive trend over the last four years, with a clear top-line improvement in 2025, improving gross margins, and solid cash generation. Below is a concise, investor-focused view drawn from the four-year quarterly statements provided (2022–2025). Key figures cited are annualized by quarter as reported in the latest available quarters.

  • Revenue growth and size of the business: 2025 Q4 operating revenue was 644,401,610 USD, up from 541,637,567 USD in 2024 Q4 and 493,647,570 USD in 2022 Q4, indicating multi-year top-line expansion.
  • Gross margin expansion: 2025 Q4 gross margin was about 34.8% (gross profit 224,517,713 on 644,401,610 revenue), higher than 2024 Q4 (~32.6%) and 2022 Q4 (~31%), signaling improved profitability discipline.
  • Improved quarterly earnings (net income): 2025 Q4 net income continuing operations was 93,270,878 USD, up from 87,667,550 USD in 2024 Q4, reflecting better quarterly profitability.
  • Earnings per share (EPS) strength: 2025 Q4 basic/diluted EPS was 0.43 USD, up from 0.39 USD in 2024 Q4, continuing the positive trend in per-share earnings.
  • Healthy operating cash flow: 2025 Q4 net cash from continuing operating activities was 125,498,718 USD, illustrating robust cash generation from core operations.
  • Strong balance sheet position and low leverage: As of 2025 Q3, total assets were ~2.938B USD, total equity ~2.495B USD, total liabilities ~441.2M USD, and short-term debt only ~4.13M USD, indicating a solid balance sheet with ample equity and modest near-term debt.
  • Dividend policy remains steady: Cash dividends per share remained at 0.12 USD, signaling a consistent return of capital to shareholders.
  • Share repurchases supporting value per share: Gentex engaged in repurchasing common equity in 2025 Q4, which can help EPS and shareholder value by reducing share count.
  • Moderate, purposeful capex: 2025 Q4 PPE purchases were ~25.7M USD, with other investing activity modestly sized in the quarter, suggesting ongoing capacity investment without pressuring near-term liquidity excessively.
  • Expense mix supportive of margins: SG&A and R&D combined for 2025 Q4 were ~104.4M USD (SG&A ~49.7M, R&D ~53.2M), a level that supports the topline and gross margin given the revenue base.
  • Historical earnings volatility: Profitability fluctuated across the four-year window (e.g., 2023 Q4 net income continuing ops was 116.9M; 2024 Q4 was 87.7M), highlighting cyclical dynamics that investors should monitor.
  • Investing cash outflows persist: Cash used for investing activities remains negative in several quarters (e.g., 2025 Q4 investing cash flow around -49.6M; 2022–2025 have multiple periods with meaningful capex and investment activity), a normal driver of future growth but a factor to watch for free cash flow trends.
  • Financing outflows pressuring cash: 2025 Q4 net cash from financing activities was -111,627,824 USD, driven by equity repurchases and dividends, which reduces cash reserves despite strong operating cash flow.
  • Ongoing net cash outflows from financing in some quarters: Across several 2023–2025 periods, significant financing outflows (e.g., large share repurchases and dividends) have tempered cash balances even as operating cash flow remained solid, adding a liquidity watchpoint if operating cash flow decelerates.
  • Short-term earnings peak in 2023; moderation in 2024: 2023 saw higher quarterly earnings levels (e.g., 2023 Q4 net income continuing ops at 116.9M) versus 2024 (87.7M), with 2025 showing a partial recovery but not a full return to 2023 highs, indicating cyclical sensitivity in earnings.
05/20/26 08:33 AM ETAI Generated. May Contain Errors.

Gentex Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Gentex's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Gentex's net income were at $384.68 million at the end of 2025, a 4.9% decrease from 2024, and a 20.8% increase since 2015. See Gentex's forecast for analyst expectations on what's next for the company.

Gentex's total operating income in 2025 was $473.94 million, based on the following breakdown:
  • Total Gross Profit: $866.71 million
  • Total Operating Expenses: $392.77 million

Over the last 10 years, Gentex's total revenue changed from $1.54 billion in 2015 to $2.53 billion in 2025, a change of 64.2%.

Gentex's total liabilities were at $437.66 million at the end of 2025, a 51.6% increase from 2024, and a 2.7% increase since 2015.

In the past 10 years, Gentex's cash and equivalents has ranged from $145.65 million in 2025 to $569.73 million in 2017, and is currently $145.65 million as of their latest financial filing in 2025.

Over the last 10 years, Gentex's book value per share changed from 5.91 in 2015 to 11.36 in 2025, a change of 92.3%.


Related Companies

Financial statements for NASDAQ:GNTX last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Billions Went Into Clean Energy. This NYSE Company Found the Gap
Billions have flowed into clean energy for decades - but the real opportunity may have formed in the gap it le...
i2i Marketing Group, LLC | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book attached
Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
This Biotech Just Flipped From Story to Execution
Avai Bio (OTCQB: AVAI) has moved into production on its new Master Cell Bank, developed alongside Austrianova,...
Equiscreen | Sponsoredtc pixel
Distracted Americans set to miss out on quadrillions
Technology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...
Brownstone Research | Sponsoredtc pixel